e-learning
resources
Barcelona 2013
Monday, 09.09.2013
Asthma and COPD: diseases with different phenotypes
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Distribution of sputum cellular phenotype in a large asthma cohort. Predicting factors for eosinophilic vs neutrophilic inflammation
F. Schleich, M. Manise, J. Sele, M. Henket, L. Seidel, R. Louis (Liege, Belgium)
Source:
Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes
Session:
Asthma and COPD: diseases with different phenotypes
Session type:
Oral Presentation
Number:
3037
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Schleich, M. Manise, J. Sele, M. Henket, L. Seidel, R. Louis (Liege, Belgium). Distribution of sputum cellular phenotype in a large asthma cohort. Predicting factors for eosinophilic vs neutrophilic inflammation. Eur Respir J 2013; 42: Suppl. 57, 3037
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Correlation of inflammatory markers of disease with sputum neutrophilia in severe asthma
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015
LATE-BREAKING ABSTRACT: Sputum transcriptome analysis yields eosinophilic and non-eosinophilic inflammatory mechanisms in UBIOPRED asthma cohort
Source: International Congress 2015 – Translational research in respiratory care: new findings
Year: 2015
Markers of eosinophilic airway inflammation in patients with severe and mild to moderate asthma
Source: International Congress 2016 – Airway biomarkers
Year: 2016
Analysis of the inflammatory profile of children with controlled and uncontrolled severe asthma
Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma
Year: 2016
Induced sputum lipid mediators in severe asthma
Source: International Congress 2016 – Translational studies in lung disease
Year: 2016
Phenotypic characteristics of asthma with small airways involvement
Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma
Year: 2016
Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma
Source: Annual Congress 2013 –Asthma
Year: 2013
Modulation of inflammation by benralizumab in eosinophilic airway disease
Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Year: 2016
Exacerbations in the subpopulations and intermediate outcome measures in COPD study (SPIROMICS, NHLBI) are associated with sputum eosinophilia but not blood eosinophilia
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016
Features of inflammation in the asthma patients with osmotic airway hyperresponsiveness
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015
Periostin as a biomarker in patients with asthma: Associations with eosinophilia and Th2 response
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015
Comparison of inflammatory markers in induced and spontaneous sputum in COPD patients
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
Proinflammatory cytokines and IP-10 differentiate neutrophilic and eosinophilic asthma subgroups
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016
Expression of nasal and bronchial IL-17F and related cytokines in frequent exacerbators with neutrophilic severe asthma
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
Distribution of the cellular inflammatory pattern in induced sputum in an eosinophilic severe asthma population.
Source: International Congress 2019 – Airway diseases and blood cells
Year: 2019
Clinical, functional and inflammatory characteristics in patients with paucigranulocytic asthma
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
Bacterial load is associated with neutrophilic sputum in severe asthmatics
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015
Airway basophils are increased and correlated with eosinophilic inflammtaion in asthma and COPD
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015
Autoreactivity and inflammatory phenotypes in patients with COPD and bronchial asthma
Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology
Year: 2016
Clinical outcomes in non-eosinophilic versus eosinophilic asthma after 12 months specialist management
Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept